Large And Small-Scale Bioprocessing Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the large and small-scale bioprocessing market size evolved in recent years?
The size of the large and small scale bioprocessing market has seen significant growth recently. The market is anticipated to increase from $59.63 billion in 2024 to $67.85 billion in 2025, representing a compound annual growth rate (CAGR) of 13.8%. Factors such as growth in the medical industry, changing regulatory standards, advancements in technology, development in pharmaceutical and biotechnology sectors, and concerns over food safety have contributed to the surge seen within the historic period.
What are the predictions for the large and small-scale bioprocessing market size in the coming years?
The market size of both large and small-scale bioprocessing is predicted to witness a fast-paced expansion in the coming years. It is set to inflate to $112.2 billion by 2029, with a CAGR of 13.4%. The forecast period’s growth can be associated with factors such as an increasing expenditure in healthcare, the growth of both pharmaceutical and biotechnology sectors, technological advancements, regulatory pressures, an increased consciousness of food safety, and the residual impact of the COVID-19 pandemic. Significant trends that will dominate the forecast period include embracing sophisticated technologies, geographical growth, sterilization services being outsourced, the implementation of sustainable practices, a mixture of sterilization techniques, and personalized sterilization solutions.
Get your large and small-scale bioprocessing market report here!
What key factors are fueling the growth of the large and small-scale bioprocessing market?
The increasing need for biologics is anticipated to fuel the expansion of both the large-scale and small-scale bioprocessing market. Biologics, which are therapeutics created from living organisms or their parts, include vaccines, blood and blood components, gene therapies, tissues, and recombinant therapeutic proteins. This surge in biologics demand is attributed to advancements in biotechnology, enhanced understanding of disease mechanisms, and the need for personalized, targeted therapies. Both small-scale and large-scale bioprocessing play crucial roles in the successful development and commercialization of biologics. Small-scale bioprocessing is imperative for early-stage development, optimization, and feasibility studies, while large-scale bioprocessing guarantees that biologics are produced efficiently, reliably, and in accordance with regulatory standards for commercial distribution. For instance, as reported by the National Library of Medicine, a US-based medical library, the Food and Drug Administration (FDA) authorized 55 new drugs in 2023, among them 29 new chemical entities (NCEs) and 25 new biological entities (NBEs). This was a 50% increase compared to the 37 approvals in 2022. Consequently, the increasing demand for biologics spurs the growth of the large-scale and small-scale bioprocessing market.
How is the global large and small-scale bioprocessing market divided into key segments?
The large and small-scale bioprocessing market covered in this report is segmented –
1) By Product: Bioreactors Or Fermenters, Cell Culture Products, Filtration Assemblies, Bioreactors Accessories, Bags And Containers, Other Products
2) By Mode: In-house, Outsourced
3) By Workflow: Downstream Processing, Fermentation, Upstream Processing
4) By Scale: Industrial Scale, Small Scale
5) By Application: Biopharmaceuticals, Specialty Industrial Chemicals, Environmental Aids
Subsegments:
1) Bioreactors Or Fermenters: Single-Use Bioreactors, Stainless Steel Bioreactors, Glass Bioreactors
2) Cell Culture Products: Cell Culture Media, Sera And Supplements, Reagents
3) Filtration Assemblies: Membrane Filters, Depth Filters, Tangential Flow Filtration Systems
4) Bioreactor Accessories: Spargers, Impellers, Sensors And Probes
5) Bags And Containers: Single-Use Bags, Storage Containers, Transfer Bags
6) Other Products: Mixers, Tubing And Connectors, Sampling Systems
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15845&type=smp
Who are the key firms paving the way for growth in the large and small-scale bioprocessing market?
Major companies operating in the large and small-scale bioprocessing market are F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, 3M Company, Takeda Pharmaceutical Company Ltd., Danaher Corporation, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Becton Dickinson and Company (BD), Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company, Lonza Group, Sun Pharmaceutical Industries Ltd., GE Healthcare Life Sciences, Sartorius AG, Dr. Reddy’s Laboratories Ltd., Alkem Laboratories Limited, Piramal Enterprises Ltd
What are the key trends shaping the future of the large and small-scale bioprocessing market?
Key players in the large and small-scale bioprocessing market are introducing cutting-edge product innovations like single-use centrifuge systems to better cater to their customers with enhanced features. These systems, which are disposable and pre-sterilized, are engineered for the separation of biological substances in bioprocessing. An example of this is the launch in September 2022 by Thermo Fisher Scientific Inc., a biotechnology firm based in the US, of their DynaSpin Single-Use Centrifuge system. This particular system is intended to optimize large-scale cell culture harvesting by simplifying the separation process, reducing the amount of depth filtration cartridges needed, and providing benefits such as increased product yield, operational efficiency, cost savings, and environmentally friendly methods in biologics production. The DynaSpin system contributes to both sustainability targets and cost reductions by drastically cutting down on material demands and waste as opposed to classic harvest systems.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15845
What regions are contributing significantly to the growth of the large and small-scale bioprocessing market?
North America was the largest region in the large and small-scale bioprocessing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Small Molecule Active Pharmaceutical Ingredient Global Market Report 2024
Small Molecule CMO/CDMO Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/small-molecule-cmo-or-cdmo-global-market-report
Small Molecule Injectable Drugs Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
